Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 1:19 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 265–288 of 457 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: No Score Clear all

Conditions: Pre-diabetes, Overweight, Metabolic Syndrome
Interventions: Diabetes Genetic Counseling, No genetic counseling; Behavioral
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 21 Years and older
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2012
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Kidney Stones
Interventions: Ultra low dose CT scan, Regular CT or Low Dose CT scan, No imaging; Radiation
Lead sponsor: Yale University; Other
Eligibility: 18 Years and older
Enrollment: 264 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Cancer, Lung Cancer, Gastro-intestinal
Interventions: PRO questionnaire, Step monitoring, Active nudge text feedback, PROStep Dashboard (clinicians); Other
Lead sponsor: Abramson Cancer Center at Penn Medicine; Other
Eligibility: 18 Years and older
Enrollment: 108 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: End Stage Liver Disease
Interventions: Eculizumab, No intervention; Drug · Other
Lead sponsor: Yale University; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: New Orleans, Louisiana

Conditions: Type I Diabetes, Pediatrics, Food Insecurity
Interventions: Community Servings, PedsQL Survey, Nutrition Counseling, SDOH Survey; Other
Lead sponsor: University of Massachusetts, Worcester; Other
Eligibility: 5 Years to 17 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Worcester, Massachusetts

Conditions: Stroke, Delirium, Spatial Neglect
Interventions: Confusion Assessment Method, Behavioral Inattention Test, Magnetic Resonance Imaging, Florida Mental Status Examination, Montreal Cognitive Assessment, Geriatric Depression Scale, Kessler Foundation Neglect Assessment Process; Diagnostic Test
Lead sponsor: Kessler Foundation; Other
Eligibility: 18 Years to 100 Years
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 2
States / cities: West Orange, New Jersey • New York, New York

Conditions: Parkinson Disease
Interventions: Not listed
Lead sponsor: Northwestern University; Other
Eligibility: 50 Years to 90 Years
Enrollment: 140 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: Evanston, Illinois

Conditions: Cirrhosis, Liver, Hepatic Cirrhosis, Hepatocellular Carcinoma, Liver Cancer
Interventions: Not listed
Lead sponsor: Epigenomics, Inc; Industry
Eligibility: 18 Years and older
Enrollment: 175 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 2
States / cities: Los Angeles, California • Pasadena, California

Conditions: HNSCC
Interventions: Alpha Lipoic Acid; Drug
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years to 100 Years
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Food Preferences, Obesity, Weight Gain
Interventions: Exposure to calorie information, Exposure to healthy labels only, Exposure to healthiness information, Exposure to physical activity equivalents, Exposure to "high in" nutrient warning labels; Behavioral
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years and older
Enrollment: 8,145 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Alzheimer Disease, Mild Cognitive Impairment, Vascular Dementia, Frontotemporal Dementia, Parkinson Disease, Multiple Sclerosis, TBI
Interventions: Boston Cognitive Assessment (BoCA); Diagnostic Test
Lead sponsor: Alzheimer's Light LLC; Industry
Eligibility: 50 Years and older
Enrollment: 10,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2029
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Posttraumatic Stress Disorder, Major Depressive Disorder
Interventions: LDAEP, Placebo, sertraline; Diagnostic Test · Drug
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years to 75 Years
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2025
U.S. locations: 2
States / cities: Boston, Massachusetts • Charleston, South Carolina

Conditions: Chest Pain
Interventions: Capsaicin; Drug
Lead sponsor: Bassett Healthcare; Other
Eligibility: 18 Years and older
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: Cooperstown, New York

Conditions: Stage I Breast Cancer
Interventions: Radiation and Endocrine Therapy (Tamoxifen, Anastrozol, Letrozole, Exemestane), Endocrine Therapy (Tamoxifen, Anastrozol, Letrozole, Exemestane); Other · Drug
Lead sponsor: NRG Oncology; Other
Eligibility: 50 Years to 70 Years
Enrollment: 1,670 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2041
U.S. locations: 812
States / cities: Birmingham, Alabama • Mobile, Alabama • Kingman, Arizona + 553 more

Conditions: Thrombocytopaenia
Interventions: Eltrombopag, Azacitidine, Placebo; Drug
Lead sponsor: Novartis Pharmaceuticals; Industry
Eligibility: 18 Years and older
Enrollment: 356 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 10
States / cities: Hartford, Connecticut • Atlanta, Georgia • Chicago, Illinois + 7 more

Conditions: Dystrophic Epidermolysis Bullosa
Interventions: Not listed
Lead sponsor: Lotus Tissue Repair, Inc.; Industry
Eligibility: Not listed
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Alzheimer Disease, Alzheimer Disease With Delusions, Alzheimer Disease With Psychosis
Interventions: [18F]-PI2620 PET scan; Diagnostic Test
Lead sponsor: Northwell Health; Other
Eligibility: 65 Years to 85 Years
Enrollment: 91 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2029
U.S. locations: 1
States / cities: Manhasset, New York

Conditions: Asthma in Children
Interventions: Bi-level Positive Airway Pressure, Sham Bi-level Positive Airway Pressure; Device
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 5 Years to 17 Years
Enrollment: 67 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Denver, Colorado

Conditions: Aortic Valve Stenosis
Interventions: Pre-habilitation; Other
Lead sponsor: WellSpan Health; Other
Eligibility: Not listed
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2021
U.S. locations: 1
States / cities: York, Pennsylvania

Conditions: Failed Labour
Interventions: Prepidil Gel, Urinary Balloon Catheter, Combined Urinary Catheter & Prepidil Gel; Drug · Device · Other
Lead sponsor: University of South Carolina; Other
Eligibility: 18 Years and older · Female only
Enrollment: 102 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2013
U.S. locations: 1
States / cities: Columbia, South Carolina

Conditions: Huntington's Disease
Interventions: Not listed
Lead sponsor: University College, London; Other
Eligibility: 11 Years to 75 Years
Enrollment: 2,500 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: Started 2017
U.S. locations: 6
States / cities: Englewood, Colorado • Washington D.C., District of Columbia • Baltimore, Maryland + 3 more

Conditions: Cancer, VTE (Venous Thromboembolism)
Interventions: Apixaban 2.5 mg twice daily, Apixaban 5 mg once daily, No anticoagulation; Drug
Lead sponsor: University of Vermont; Other
Eligibility: 18 Years and older
Enrollment: 996 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2035
U.S. locations: 1
States / cities: Burlington, Vermont

Conditions: Necrosis
Interventions: Necrotizing soft tissue infections (NSTIs); Other
Lead sponsor: Methodist Health System; Other
Eligibility: 18 Years to 89 Years
Enrollment: 1,010 participants
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Mental Health Wellness 1, Health Care Utilization, Financial Hardship, Education, Professional
Interventions: Guaranteed Income, Peer learning circles, Financial coaching; Other · Behavioral
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years to 24 Years
Enrollment: 300 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: San Francisco, California

Search by objective public record fields.

Genetic Counseling and Lifestyle Change for Diabetes Prevention

Feasibility and Impact of a Decision Rule for Imaging of Emergency Department Patients With Suspected Kidney Stone

PROStep: A Feasibility Trial Using PROs and Step Data to Monitor Patients With Lung and GI Cancers

Pilot Trial of Eculizumab Therapy to Reduce Preservation Injury in Human Macrosteatotic Liver Transplantation

Food is Medicine in Pediatric Patients With Diabetes

Spatial Neglect and Delirium After Stroke

Spoken Discourse Biomarker of PD Cognitive Impairment

HCCBloodTest for Detection of Hepatocellular Carcinoma (HCC)

Alpha Lipoic Acid to Decrease Pain and Side Effects in Concurrent Treatment of HNSCC

Online Food and Beverage Labels and Vending Machine Selections

Longitudinal Cognitive Assessment by BoCA

Predicting SSRI Efficacy in Veterans With PTSD

Chest Pain Perception and Capsaicin Sensitivity in Patients With Acute Cardiac Ischemia

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

A Study of Eltrombopag or Placebo in Combination With Azacitidine in Subjects With International Prognostic Scoring System (IPSS) Intermediate-1, Intermediate-2 or High-risk Myelodysplastic Syndromes (MDS)

Prospective, Longitudinal Natural History Study in Dystrophic Epidermolysis Bullosa

Tau Networks in Psychotic Alzheimer's Disease

BiPAP in Pediatric Moderate to Severe Asthma Randomized Control Trial

Prehabilitation for Patients Undergoing Transcatheter Aortic Valve Replacement

Comparison of Pre-Induction Cervical Ripening

HDClarity: a Multi-site Cerebrospinal Fluid Collection Initiative to Facilitate Therapeutic Development for Huntington's Disease

DOAC - Dosing Options in AntiCoagulation Prophylaxis

NECROtizing Soft Tissue Infections and Their Scoring System

Black Economic Equity Movement